Clinical Trials Browser

Not yet recruiting × CA-4948 × Clear all

NCT07107750 2026-02-04

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Phase 1 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms